GlassScriptPhysician profile
Kailey Harris
NPI 1770176919
$1,088.97
in general payments reported to CMS, 2019-2025
15 companies · $357 in 2025
The $357 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $322 · 2022: $49.68 · 2024: $361 · 2025: $357.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $718.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $717.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $250.45 | 2021-2024 | Imfinzi |
| Novartis Pharmaceuticals Corporation | $165.60 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $124.72 | 2025 | Opdivo |
| Puma Biotechnology, INC. | $117.75 | 2021 | |
| Tactile Systems Technology INC | $83.00 | 2024 | Flexitouch Plus, Entre Plus |
| Ge Healthcare | $79.38 | 2024 | |
| Astellas Pharma US INC | $77.99 | 2021 | |
| Abiomed | $40.65 | 2024 | Impella |
| Regeneron Healthcare Solutions, INC. | $33.80 | 2022 | |
| Stemline Therapeutics INC. | $27.96 | 2025 | Orserdu |
| Gilead Sciences, INC. | $23.00 | 2025 | Trodelvy |
| Eisai INC. | $20.18 | 2024 | |
| Genzyme Corporation | $15.88 | 2022 | |
| Servier Pharmaceuticals LLC | $15.51 | 2025 | |
| Adc Therapeutics America, INC. | $13.10 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kailey Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.